Srm Formulation Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 11-01-2025
- Paid Up Capital ₹ 0.10 M
as on 11-01-2025
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.50 Cr
as on 11-01-2025
- Revenue %
(FY 2022)
- Profit 122.53%
(FY 2022)
- Ebitda 124.77%
(FY 2022)
- Net Worth 9.20%
(FY 2022)
- Total Assets 0.01%
(FY 2022)
About Srm Formulation
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.50 Cr.
Sharad Kolte, Rasika Warkhade, Shubhangi Shastri, and One other member serve as directors at the Company.
- CIN/LLPIN
U24303MH2020PTC344254
- Company No.
344254
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Aug 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Srm Formulation Private Limited offer?
Srm Formulation Private Limited offers a wide range of products and services, including Diagnostic Medical Imaging Equipment, Ultrasound Accessories, Animal Medicines & Health Care, Veterinary Medicines, Animal Nutraceuticals, Bird Food, Poultry & Animal Food, Animal Feed Supplement, Nutraceuticals & Dietary Supplements, Mineral Supplement.
Who are the key members and board of directors at Srm Formulation?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sharad Kolte  | Director | 22-Aug-2020 | Current |
| Rasika Warkhade | Director | 22-Aug-2020 | Current |
| Shubhangi Shastri | Director | 22-Aug-2020 | Current |
| Sneha Rathi | Director | 22-Aug-2020 | Current |
Financial Performance of Srm Formulation.
Srm Formulation Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 122.53% increase in profit. The company's net worth moved up by a moderate rise of 9.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Srm Formulation?
In 2022, Srm Formulation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 Aug 2023 | ₹3.50 Cr | Open |
How Many Employees Work at Srm Formulation?
Srm Formulation has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Srm Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Srm Formulation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
